Biomedical subjects
Publications and source records attributed to H Steger.
Explore the source record for details and available documents.
Various copper compounds (CuSO4, Cu-glycinate, Cu-lactate, Cu-citrate) were applied subcutaneously, intramuscularly, and intravenously to 17 barrows, doses being up to 50 mg Cu, while doses between 0.5 g and 1.0 g CuSO4 were orally administered. Curves of copper levels in the serum then were checked at different times. In response to intravenous application, copper levels reached maximum values as early as after two minutes and dropped to the normal about 90 minutes from application. Subcutaneous and intramuscular applications had but little effect on serum copper levels, while oral administration actually had none at all.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Three independent experiments were conducted with cyclic gilts kept under different conditions (2 x 12 on platforms and 100 from production unit), i.e. hormonally unaffected or under the usual conditions of synchronised oestrus (100 mg Suisynchron per animal and die over 20 days followed by 1,000 I.U. PMS and again followed, three days later, by 250 I.U. HCG). Blood samples were repeatedly drawn from the jugular vein and brachiocephalic vein during phases of treatment and oestrus. Acid and alkaline phosphatases were determined immediately in the plasms, and the results were calculated by variance analysis. Synchronisation, using Suisynchron, proved conducive to lowering with significance (P less than 0.01) the levels of acid and alkaline phosphatases. All changes in phosphatase values were not in full conformity within the experiments during the other phases of treatment. Phosphatase levels were not affected by discontinuation of Suisynchron nor by administration of Gn hormone. The levels of acid and alkaline phosphatases in biotechnically treated animals appeared to be lower than those in animals with spontaneous oestrus at the time of full oestrus. While the findings were of period-specific significance (P less than 0.01), the results obtained from the individual animal failed to provide specific information, since gaps were too wide between animals and between animals, on the one hand, and periods, on the other (P less than 0.01).
Two groups of twelve gilts each kept on platforms were synchronised in two passes over 20 days, using 100 mg Suisynchron per animal and die followed by PMS treatment (1,000 I.U. Intergonan) and HCG treatment (250 I.U.). Complement fixation occurred five days after the first hormone application and was followed twelve to 15 days later by another phase of treatment, using Gravigonan (250 I.U. follicle-stimulating hormone (FSH), 500 I.U. HCG, 1 mg oestradiol benzoate in 10 ml serum of swine). Blood samples were continuously drawn during the various phases of treatment and cycle from the above animals as well as from 20 gilts synchronised in the above way and from another 20 untreated gilts. Protein-fixed iodine and copper levels were assessed from those samples. The protein-fixed iodine and copper levels of the blood were significantly reduced (P less than 0.01) by synchronisation, using Suisynchron. None of the two parameters was particularly affected by PMS and HCG treatments. Blood-borne protein-fixed iodine and copper was increased by administration of gonabione. Both parameters went up further during full oestrus at which date they were higher in untreated animals than in synchronised. (Protein-fixed iodine: 3.50/226micrograms/100 ml; P less than 0.01; copper: 0.283/0.234 mg/100 ml; P less than 0.01).
Suisynchron treatment was applied to platform-kept gilts over 20 days. The dosage was 100 mg per animal and die. This was followed by 1,000 I.U. PMS and 250 I.U. HCG. Artificial insemination was applied five days after the first hormone administration and followed by one Gravigonan injection after another twelve to 15 days. Blood samples were drawn from those animals as well as from 20 gilts synchronised in the above way and another 20 untreated gilts from a production unit during the various phases of treatment and cycle. Those samples were used for assessment of cholesterol, lipoid-P, free fatty acids, triglyceride, and beta-lipoproteids. The levels of free and total cholesterol went up along with Suisynchron feeding, whereas lipoid-P and beta-lipoproteids declined. Free fatty acid levels went down with significance (P less than 0.01), and triglycerides increased (P less than 0.05). Cholesterol levels were not altered by PMS/HCG administration. The levels of lipoid-P, free fatty acids, and beta-lipoproteids rose to their magnitudes prior to Suisynchron treatment. Tirglycerides rose by 50 per cent. At the time of full oestrus triglyceride levels doubled (P less than 0.01). Unimportant rises were recorded also for cholesterol, beta-lipoproteids, free fatty acids, and lipoid-P. In animals with spontaneous oestrus all lipid parameters were ligher than in sows with full oestrus after synchronisation.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Oral glucose tolerance tests (50 g/m2 body surface) were performed in fifty-two children and adolescents (28 girls and 24 boys) aged 3.1 to 16.8 (mean +/- SD 11.4 +/- 3.28) years. Mean overweight of the patients was calculated to be 69.7 +/- 28.5%. Plasma glucose and immunoreactive insulin were determined before, and 15, 30, 60, 90, 120 and 180 minutes after the oral glucose load. According to the criteria of the National Diabetes Data Group six (11.5%) of the subjects had abnormal glucose test profiles (fasting glucose concentrations over 140 mg/dl or after 120 minutes above 140 mg/dl), and in four of the six probands we could detect elevated fasting insulin levels (above 17 E/ml) as well. In twenty-three out of forty-eight serum samples (47.9%) basal insulin levels were elevated. No correlation between age, sex, duration of overweight with glucose or insulin levels could be found. Our results are in accordance with findings in obese adults reflecting a high prevalence of impaired glucose tolerance and hyperinsulinemia in obese children and adolescents. On the other hand pathophysiologic relevance and clinical importance of these findings in obese children of an impaired glucose tolerance and hyperinsulinemia is questionable in view of the rapid normalization after weight loss.
Report on a girl with Seckel-syndrome (bird-headed dwarfism). In addition to the known symptomatology she had a congenital heart failure (ASD II, VSD, PDA). Endocrine evaluation revealed decreased growth hormone stimulation. In the CT-scan of the skull enlarged ventricles were demonstrated.